Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
89bio (ETNB) has issued an announcement.
89bio, Inc. has appointed Francis Sarena as its new Chief Operating Officer, effective immediately. Mr. Sarena brings a wealth of experience from his previous high-level roles in multiple biotech companies, including Apexigen and Five Prime Therapeutics. His comprehensive background in business development and operations is complemented by a solid educational foundation with a B.S. in Finance and a J.D. He will receive an annual salary of $500,000, with the potential for a 40% bonus, and has been granted stock options and restricted stock units as part of his compensation package.
For detailed information about ETNB stock, go to TipRanks’ Stock Analysis page.